Literature DB >> 7569684

Influence of human luteinizing hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro.

C M Kurbacher1, W Jäger, J A Kurbacher, A Bittl, L Wildt, N Lang.   

Abstract

In the present study, the influence of human luteinizing hormone(hLH) on the growth and the CA 125 secretion of primary ovarian carcinoma cell cultures derived from 11 previously untreated patients was investigated. Two different patterns of in vitro growth of unstimulated ovarian carcinoma cells could be detected: 5 cell cultures in which no changes of cell number were observed during an incubation period of 6 days (group A) and 6 cell cultures which grew without any hormonal support (group B). All tumors of group A showed enhanced cell proliferation when hLH was added to the culture medium, reaching a maximum at dosages of 100 mIU/ml on day 2 after incubation, while such an effect was not observed in group B. In most cases, no positive correlation was found between hLH-induced cell growth and CA 125 release. Our findings demonstrated a dose-dependent hLH-induced stimulation of epithelial ovarian tumors in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569684     DOI: 10.1159/000217954

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  3 in total

1.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

2.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

3.  Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.

Authors:  Shigang Xiong; Paulette Mhawech-Fauceglia; Denice Tsao-Wei; Lynda Roman; Rajesh K Gaur; Alan L Epstein; Jacek Pinski
Journal:  BMC Cancer       Date:  2019-11-15       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.